Cardiac Guidance vs Cardio-TriTest

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Cardiac Guidance

by Caption Health

Cardio-TriTest

by Cardio-Phoenix

AI Verdict

Tool A, Cardiac Guidance, focuses on democratizing cardiac ultrasound acquisition and interpretation, enabling non-experts to obtain diagnostic-quality images and measurements like ejection fraction. In contrast, Tool B, Cardio-TriTest, is a multi-modal diagnostic device that combines ECG, PCG, and MCG to provide a synchronized, AI-powered analysis of heart bio-signals for comprehensive cardiovascular disease detection. While both aim to improve cardiac assessment, they utilize distinct diagnostic modalities—ultrasound imaging versus bio-signal analysis—making them complementary rather than direct alternatives.

Choose Cardiac Guidance if…

Choose Cardiac Guidance if your primary goal is to empower non-expert ultrasound users to acquire diagnostic-quality cardiac ultrasound images rapidly at the point of care. This tool is ideal for emergency medicine, critical care, or primary care settings where immediate cardiac assessment, including automated ejection fraction calculation, is needed without requiring a specialized sonographer.

View Cardiac Guidance →

Choose Cardio-TriTest if…

Choose Cardio-TriTest if you require a comprehensive, multi-modal cardiovascular screening and early detection solution within a primary care or clinical setting. This device is best suited for practices looking to integrate synchronized ECG, PCG, and MCG bio-signal analysis to gain a holistic and visually correlated view of cardiac health for initial diagnosis and ongoing monitoring.

View Cardio-TriTest →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Cardiac Guidance	Cardio-TriTest
Deployment	Caption Guidance is deployed in acute point-of-care settings, including emergency and anesthesiology departments and critical care units. It is also used in doctors' offices and can be used for at-home care.	On-premise (device)
FDA Status	Cleared AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Cardiac Guidance

Cardiac Guidance (Tool A) explicitly focuses on making complex cardiac ultrasound acquisition accessible to non-expert users through real-time AI guidance, turn-by-turn instructions, and automated quality assessment. This strong emphasis on user guidance for a technically demanding procedure gives it an edge in usability over Cardio-TriTest (Tool B), which is described as non-invasive and quick but lacks similar explicit guidance features for the clinician.

Clinical Value

Tie

Both tools offer distinct and significant clinical value. Cardiac Guidance (Tool A) democratizes access to diagnostic-quality cardiac ultrasound by enabling non-experts to acquire and interpret images, including automated EF calculation. Cardio-TriTest (Tool B) provides a novel 3-in-1 multi-modal diagnostic approach combining ECG, PCG, and MCG for earlier and more comprehensive cardiovascular disease detection. Their value propositions address different aspects of cardiac care, making a direct comparison of superiority difficult.

Pricing & Value

Tie

Neither Cardiac Guidance (Tool A) nor Cardio-TriTest (Tool B) provides transparent pricing information, both stating 'contact vendor' or 'contact for pricing'. Without specific cost details, it is impossible to assess their relative value proposition or make an informed judgment on pricing transparency.

Enterprise Readiness

Cardiac Guidance

Cardiac Guidance (Tool A) is deployed as a 'Software accessory integrated with compatible general purpose diagnostic ultrasound systems,' indicating strong potential for seamless integration into existing healthcare IT infrastructure. While both are FDA-cleared and HIPAA compliant, Cardio-TriTest (Tool B)'s 'device-based' deployment might present more challenges for large-scale integration and management within an enterprise setting.

Innovation

Tie

Both tools demonstrate significant innovation in different areas. Cardiac Guidance (Tool A) innovates by using AI to guide real-time ultrasound image acquisition, making a complex diagnostic skill accessible to a broader range of healthcare professionals. Cardio-TriTest (Tool B) innovates by combining and synchronizing three distinct bio-signals (ECG, PCG, MCG) into a single AI-powered diagnostic device for comprehensive and potentially earlier cardiovascular disease detection. Both represent forward-thinking advancements in cardiac diagnostics.

Support & Docs

Tie

Both companies appear to offer standard support and documentation. Caption Health (Tool A) provides customer support, training resources, online documentation, and technical assistance. Cardio-Phoenix Inc. (Tool B) offers technical support and training, with documentation available to registered users. The available information does not provide sufficient detail to distinguish a superior offering in terms of support and documentation.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Cardiac Guidance	Cardio-TriTest
Name	Cardiac Guidance	Cardio-TriTest
Company	Caption Health	Cardio-Phoenix Inc.
Description	FDA-cleared AI tool that empowers healthcare professionals to acquire and interpret diagnostic-quality cardiac ultrasound images at the point of care, democratizing access to critical cardiac assessments.	AI-powered 3-in-1 diagnostic device combining ECG, PCG, and MCG to synchronize and visually correlate heart bio-signals for earlier and more comprehensive cardiovascular disease detection in primary care.
Key Features	Real-time AI guidance for cardiac ultrasound image acquisition; Turn-by-turn on-screen probe movement instructions; Automated quality assessment with a 'Quality Meter'; Auto-capture of diagnostic-quality images and video clips; Automated left ventricular ejection fraction (EF) calculation (Caption Interpretation); Support for 10 standard echocardiographic views (e.g., PLAX, AP4, AP2); Compatibility with point-of-care ultrasound systems; Designed for use by non-expert ultrasound users	3-in-1 diagnostic device (ECG, PCG, MCG); 12-Lead Electrocardiograph (ECG); 4 Lead Phonocardiograph (PCG); 4 Lead Mechanocardiograph (MCG); Synchronized bio-signal acquisition; Visual correlation of heart bio-signals; AI-powered analysis for heart disease detection; Non-invasive test procedure
Categories	Cardiology AI, Radiology & Imaging AI	Cardiology AI
Specialties	Cardiology, Emergency Medicine, Radiology	Cardiology, Family Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring Cardiac Guidance and Cardio-TriTest.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows for cardiovascular assessment, particularly for initial screening versus advanced diagnostics?

Cardiac Guidance is designed to integrate with compatible point-of-care ultrasound systems, providing real-time AI guidance for image acquisition and automated LVEF calculation, making it suitable for immediate cardiac assessments by non-expert ultrasound users. Cardio-TriTest, as a device-based 3-in-1 diagnostic tool combining ECG, PCG, and MCG, is positioned for earlier and more comprehensive cardiovascular disease detection, particularly in primary care settings.

What specific clinical metrics or diagnostic capabilities do these tools offer, and how do their respective AI analyses contribute to diagnostic accuracy for different cardiovascular conditions?

Cardiac Guidance provides AI-guided acquisition of diagnostic-quality cardiac ultrasound images, including automated quality assessment and left ventricular ejection fraction (EF) calculation, supporting 10 standard echocardiographic views. Cardio-TriTest offers AI-powered analysis of synchronized 12-Lead ECG, 4 Lead PCG, and 4 Lead MCG bio-signals to visually correlate and detect cardiovascular disease.

Given that one tool focuses on ultrasound guidance and the other on multi-signal analysis, what is the expected learning curve for a physician in a primary care or emergency setting to effectively utilize each tool for accurate patient assessment?

Cardiac Guidance is explicitly 'designed for use by non-expert ultrasound users' with 'turn-by-turn on-screen probe movement instructions,' suggesting a relatively low learning curve for image acquisition. Cardio-TriTest combines three distinct bio-signals (ECG, PCG, MCG) with AI-powered analysis for comprehensive detection, which may require familiarity with interpreting these synchronized modalities, especially for primary care physicians.

What level of integration with existing Electronic Health Record (EHR) systems can be expected from each tool, specifically regarding data transfer, reporting, and workflow automation?

The provided information does not detail the specific EHR integration capabilities for either Cardiac Guidance or Cardio-TriTest. Physicians would need to inquire further with each vendor regarding data transfer, reporting features, and potential for workflow automation.

For healthcare systems considering a multi-site rollout, what are the key considerations for implementation, training, and ongoing support for each tool, especially concerning hardware versus software dependencies?

Cardiac Guidance is a software accessory integrated with compatible general-purpose diagnostic ultrasound systems, suggesting implementation would involve software deployment across existing or new POCUS devices. Cardio-TriTest is described as a 'device-based' solution for clinical settings, implying that multi-site rollout would involve the physical deployment and management of individual diagnostic devices.